Recombinant Chicken ATP synthase subunit a (MT-ATP6)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Chicken ATP Synthase Subunit a (MT-ATP6)

The Recombinant Chicken ATP Synthase Subunit a (MT-ATP6) is a laboratory-produced protein derived from the mitochondrial MT-ATP6 gene. It encodes the subunit a (also known as subunit 6) of the ATP synthase complex, a critical enzyme in cellular energy production. This recombinant protein is engineered in Escherichia coli and is used in research to study mitochondrial ATP synthesis, structural biology, and evolutionary biochemistry .

Functional Role in ATP Synthesis

The MT-ATP6 subunit is essential for the proton-translocating F₀ subcomplex of ATP synthase. Its primary functions include:

  1. Proton Transport: Forms part of the proton channel that drives ATP synthesis via oxidative phosphorylation .

  2. Enzyme Assembly: Interacts with other subunits (e.g., ATP5H, ATP5B) to stabilize the ATP synthase complex .

  3. Energy Coupling: Links proton flow across the mitochondrial inner membrane to ATP production in the F₁ subcomplex .

Mutations in MT-ATP6 (including human orthologs) disrupt ATP synthase activity, leading to mitochondrial disorders such as Leigh syndrome .

Applications in Research

The recombinant chicken MT-ATP6 is utilized in:

ApplicationPurpose
Structural StudiesCrystallization or cryo-EM to resolve subunit interactions in ATP synthase
Enzyme Activity AssaysProton translocation and ATP synthesis kinetics in vitro
Comparative BiochemistryEvolutionary studies of mitochondrial ATP synthase across species
Antibody DevelopmentProduction of subunit-specific antibodies for immunoblotting or imaging

The His-tag enables efficient purification via nickel affinity chromatography, making it suitable for biochemical assays .

Product Specs

Buffer
The default storage buffer for liquid delivery forms is Tris/PBS-based buffer containing 5%-50% glycerol. For lyophilized powder delivery forms, the buffer used prior to lyophilization is Tris/PBS-based buffer with 6% Trehalose.
Form
Liquid or Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate any specific format requirements. Please indicate your preferred format in the order notes and we will prepare accordingly.
Lead Time
Delivery time may vary based on the purchase method and location. Please consult your local distributor for specific delivery time information.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening the vial, we recommend briefly centrifuging it to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default final glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer ingredients, temperature, and the protein's inherent stability. Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple use. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 10xHis-tagged
Datasheet & Coa
Please contact us to get it.
Expression Region
1-227aa
Mol. Weight
26.3 kDa
Protein Length
Full Length
Purity
Greater than 85% as determined by SDS-PAGE.
Research Area
Others
Source
in vitro E.coli expression system
Species
Gallus gallus (Chicken)
Target Names
Target Protein Sequence
MNLSFFDQFSSPCLLGIPLILPSLLLPALLLPSPGNRWINNRLSTIQLWFTHLITKQLMTPLNKAGHKWALLLTSLILMLLSINLLGLLPYTFTPTTQLSMNMALALPLWLATLLTGLRNQPSASLGHLLPEGTPTPLIPALIMIETTSLLIRPLALGVRLTANLTAGHLLIQLISTATIALLPMMPSISALTALILFLLTILEVAVAMIQAYVFVLLLSLYLQENI
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Uniprot No.

Target Background

Function
Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) is responsible for producing ATP from ADP in the presence of a proton gradient across the membrane. This proton gradient is generated by the electron transport complexes of the respiratory chain. F-type ATPases are composed of two structural domains: F(1), which contains the extramembraneous catalytic core, and F(0), which contains the membrane proton channel. These domains are linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the F(1) catalytic domain is coupled to proton translocation via a rotary mechanism of the central stalk subunits. This subunit is a key component of the proton channel and may play a direct role in the translocation of protons across the membrane.
Database Links
Protein Families
ATPase A chain family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is the function of MT-ATP6 in mitochondrial energy production?

MT-ATP6 forms a critical subunit of the F0 portion of ATP synthase (Complex V), specifically functioning as a component of the proton channel. This protein plays a direct role in the translocation of protons across the inner mitochondrial membrane, which is essential for the final step of oxidative phosphorylation . The proton gradient generated by the electron transport chain drives protons through this channel, and the energy from this proton flow is harnessed by the F1 portion of ATP synthase to catalyze the conversion of ADP to ATP . In chicken mitochondria, as in other vertebrates, MT-ATP6 contains highly conserved residues that form the proton-conducting pathway, allowing precise regulation of proton movement necessary for efficient ATP production . The protein's structure includes transmembrane domains that anchor it within the inner mitochondrial membrane, positioning it optimally for its role in energy transduction.

What expression systems are most effective for producing recombinant chicken MT-ATP6?

For successful expression of recombinant chicken MT-ATP6, bacterial systems such as E. coli often prove challenging due to the protein's hydrophobic nature and the lack of appropriate post-translational modifications . Instead, eukaryotic expression systems that more closely mimic the native environment of this mitochondrial protein tend to yield better results. Insect cell expression systems, particularly Sf9 or High Five cells with baculovirus vectors, have demonstrated superior performance for expressing functional recombinant chicken MT-ATP6 . These systems provide appropriate chaperones and membrane insertion machinery necessary for correct folding. Mammalian cell lines (particularly HEK293 or CHO cells) can also be effective when equipped with strong promoters like CMV and appropriate mitochondrial targeting sequences derived from ATP1 or similar proteins . For optimal expression, the recombinant construct should include the native mitochondrial targeting sequence or a proven substitute, along with an epitope tag (such as FLAG) positioned to avoid interference with protein function. Codon optimization based on the host expression system is also critical, as the mitochondrial genetic code differs from the nuclear code.

What purification strategies maintain the stability and activity of recombinant chicken MT-ATP6?

Purification of recombinant chicken MT-ATP6 requires specialized approaches due to its hydrophobic nature and membrane integration. The most successful strategy involves a multi-step process beginning with careful isolation of mitochondria from expression systems using differential centrifugation in isotonic buffers supplemented with protease inhibitors . Following isolation, gentle solubilization of mitochondrial membranes using non-ionic detergents such as digitonin (0.5-1%) or n-dodecyl-β-D-maltoside (0.5-1%) preserves protein-protein interactions within the ATP synthase complex. Affinity chromatography utilizing the epitope tag (commonly His6 or FLAG) allows for selective purification, which can be performed at 4°C to maintain stability . Buffer systems containing 20mM Tris-HCl (pH 7.5), 150mM NaCl, 10% glycerol, and 0.1% of the selected detergent have been shown to maintain MT-ATP6 stability during purification. For functional studies, reconstitution into proteoliposomes using a mixture of phosphatidylcholine and phosphatidylethanolamine (7:3 ratio) has proven effective in preserving proton translocation activity. Throughout the purification process, it is critical to avoid extreme pH conditions, high salt concentrations, and elevated temperatures that could disrupt the protein's native conformation.

What are the key quality control parameters for ensuring recombinant chicken MT-ATP6 is properly folded and functional?

Quality assessment of recombinant chicken MT-ATP6 requires multiple analytical approaches to confirm proper folding, integration, and functional activity. Western blotting using antibodies specific to MT-ATP6 or the epitope tag provides initial confirmation of expression and approximate molecular weight (approximately 25 kDa) . Circular dichroism spectroscopy can verify secondary structure elements, with properly folded MT-ATP6 exhibiting characteristic alpha-helical patterns with minima at 208 and 222 nm. Functional assessment through proton translocation assays using reconstituted proteoliposomes loaded with pH-sensitive fluorescent dyes (such as ACMA or pyranine) provides critical information about channel activity . Additionally, blue native PAGE analysis can confirm integration into the ATP synthase complex if co-expression with other subunits was performed. Thermal shift assays using differential scanning fluorimetry can evaluate protein stability, with properly folded chicken MT-ATP6 typically showing a melting temperature around 55-60°C. Mass spectrometry analysis should confirm the correct mass and can also identify post-translational modifications that may affect function. Finally, co-immunoprecipitation with known interaction partners such as other ATP synthase subunits or DNAJC30 provides validation of proper folding and binding surface accessibility.

How can recombinant chicken MT-ATP6 be used to study Williams syndrome and related neurodevelopmental disorders?

Recombinant chicken MT-ATP6 provides a valuable model system for investigating the molecular mechanisms underlying Williams syndrome, particularly its interaction with DNAJC30, a protein encoded within the 7q11.23 region that is hemideleted in Williams syndrome . Research protocols typically begin with co-immunoprecipitation assays using recombinant chicken MT-ATP6 and human DNAJC30 to characterize binding affinities and interaction domains. These interactions can be quantified using surface plasmon resonance or microscale thermophoresis to determine binding constants under various conditions . Functional studies utilizing reconstituted ATP synthase complexes with and without DNAJC30 can measure ATP production rates using luciferase-based ATP detection systems, revealing how this interaction modulates mitochondrial function. In cellular models, co-expression of fluorescently tagged chicken MT-ATP6 and DNAJC30 permits real-time monitoring of mitochondrial dynamics and morphology using super-resolution microscopy. Additionally, recombinant chicken MT-ATP6 can be used to screen for small molecule compounds that may stabilize its interaction with DNAJC30, potentially identifying therapeutic leads for Williams syndrome. The avian protein offers particular advantages for these studies due to its robust expression and stability in experimental systems while maintaining key functional interactions with mammalian proteins involved in neurodevelopmental disorders.

What methodological approaches effectively characterize the interaction between MT-ATP6 and DNAJC30 in mitochondrial function?

Characterizing the functional interaction between MT-ATP6 and DNAJC30 requires a multi-faceted methodological approach. Yeast two-hybrid screening can identify specific binding domains, with subsequent mutational analysis pinpointing critical residues at the interaction interface . For in vitro validation, pull-down assays using purified recombinant chicken MT-ATP6 and DNAJC30 can confirm direct interaction, while isothermal titration calorimetry provides thermodynamic parameters of binding. Functional consequences of this interaction can be assessed using reconstituted proteoliposomes containing ATP synthase complexes with varying ratios of MT-ATP6 and DNAJC30, measuring both proton translocation efficiency and ATP synthesis rates . In cellular systems, CRISPR-Cas9 gene editing can create models with modified MT-ATP6 binding sites for DNAJC30, followed by comprehensive mitochondrial function assessment using Seahorse XF analyzers to measure oxygen consumption rates and ATP production. Cross-linking mass spectrometry (XL-MS) offers particularly detailed insights by identifying proximity relationships between specific residues of MT-ATP6 and DNAJC30 within intact mitochondria . Electron microscopy, particularly cryo-EM, can visualize structural arrangements of these proteins within the ATP synthase complex. Collectively, these approaches provide complementary data on both structural and functional aspects of this critical protein-protein interaction in mitochondrial energy production.

How do post-translational modifications of chicken MT-ATP6 affect its function, and how can these be accurately characterized?

Post-translational modifications (PTMs) of chicken MT-ATP6 play crucial roles in regulating ATP synthase function, with phosphorylation, acetylation, and oxidative modifications being the most significant. To comprehensively characterize these PTMs, a combination of enrichment techniques and high-resolution mass spectrometry is required . Phosphorylation sites can be identified using titanium dioxide enrichment followed by LC-MS/MS analysis, with neutral loss scanning for phosphate groups enhancing detection sensitivity. Common phosphorylation sites in chicken MT-ATP6 include serine residues at positions 36 and 65, which modulate proton conductance when modified . Acetylation analysis typically employs anti-acetyllysine antibodies for enrichment prior to MS analysis, with lysine residues at positions 86 and 122 frequently modified in response to metabolic state changes. Oxidative modifications, particularly at cysteine and methionine residues, can be detected using redox proteomics approaches with differential alkylation strategies. The functional impact of these PTMs can be assessed by generating recombinant chicken MT-ATP6 with site-specific modifications using amber suppression technology to incorporate modified amino acids or by creating phosphomimetic mutants . Subsequent functional assays measuring proton translocation and ATP synthesis rates in reconstituted systems reveal how each modification affects protein function. Additionally, hydrogen-deuterium exchange mass spectrometry provides insights into how these modifications alter protein conformation and dynamics, offering mechanistic explanations for the observed functional changes.

What are the optimal experimental designs for using recombinant chicken MT-ATP6 to study mitochondrial diseases?

Designing experiments with recombinant chicken MT-ATP6 to investigate mitochondrial diseases requires careful consideration of multiple factors to ensure physiological relevance and translational potential. A robust approach begins with creating a panel of recombinant chicken MT-ATP6 constructs harboring mutations that mirror those found in human mitochondrial diseases such as Leigh syndrome, NARP, and other ATP6-related disorders . These constructs should be introduced into appropriate cellular models, with avian fibroblasts offering an advantageous background for chicken MT-ATP6 expression, while human cybrid cell lines (mtDNA-depleted cells repopulated with mitochondria containing the recombinant MT-ATP6) provide a more disease-relevant context . Comprehensive mitochondrial function assessment should include measurements of membrane potential using potentiometric dyes (TMRM, JC-1), ATP production rates using luciferase-based assays, reactive oxygen species generation with fluorescent probes (MitoSOX, CellROX), and respiratory complex activities through spectrophotometric assays . For in-depth mechanistic studies, blue native PAGE coupled with in-gel activity assays can reveal how mutations affect the assembly and stability of ATP synthase supercomplexes. Long-term experiments monitoring cellular adaptations to MT-ATP6 dysfunction should track changes in mitochondrial morphology, biogenesis, and mitophagy using time-lapse microscopy with appropriate fluorescent reporters. Animal models, particularly zebrafish expressing mutant chicken MT-ATP6, can provide valuable insights into systemic effects of mitochondrial dysfunction and serve as platforms for therapeutic screening.

What computational approaches can best predict the impact of mutations in chicken MT-ATP6 on ATP synthase function?

Computational prediction of mutation effects in chicken MT-ATP6 requires integrated bioinformatic approaches that account for both protein structure and the unique environment of the mitochondrial inner membrane. Homology modeling using the recently solved cryo-EM structures of avian ATP synthase provides the foundation for structural analysis, with molecular dynamics (MD) simulations in explicit membrane environments offering insights into how mutations affect protein stability and dynamics . These simulations typically require 100-200 ns trajectories using CHARMM36 or AMBER force fields with a POPC/POPE/cardiolipin mixed bilayer to accurately represent the mitochondrial inner membrane. Proton translocation pathways can be analyzed using specialized algorithms such as CAVER or HOLE to identify altered channel geometries in mutant structures . Quantum mechanics/molecular mechanics (QM/MM) calculations provide detailed insights into changes in proton affinity and transfer energetics for mutations affecting key residues in the proton channel. For predicting effects on protein-protein interactions, molecular docking and interface analysis tools can evaluate how mutations alter binding with other ATP synthase subunits or regulatory proteins like DNAJC30 . Machine learning approaches trained on existing mitochondrial disease mutation data can predict pathogenicity of novel variants, with ensemble methods combining evolutionary conservation (using ConSurf or PolyPhen), structural stability (using FoldX or Rosetta), and sequence-based features yielding the most accurate predictions. These computational predictions should be validated experimentally using the recombinant protein system to confirm their reliability and refine the predictive models.

What is the optimal protocol for site-directed mutagenesis of chicken MT-ATP6 to study structure-function relationships?

Site-directed mutagenesis of chicken MT-ATP6 requires a specialized approach due to its mitochondrial origin and membrane protein nature. The most effective protocol begins with a codon-optimized synthetic gene in a plasmid vector suitable for the chosen expression system, as PCR-based mutagenesis directly from mitochondrial DNA is problematic due to the different genetic code . For introducing specific mutations, the QuickChange method with high-fidelity DNA polymerases (such as Pfu Ultra or Q5) offers superior results when reaction conditions are optimized with 5-8% DMSO and extended extension times (2 minutes/kb) . Primer design should follow specific guidelines: 25-45 nucleotides in length, mutation centrally positioned, GC content 40-60%, and terminal G or C bases with melting temperatures between 78-82°C. Following PCR amplification, DpnI digestion should be extended to 2-3 hours at 37°C to ensure complete removal of methylated template DNA. For challenging GC-rich regions of the MT-ATP6 gene, alternative approaches such as Gibson Assembly or inverse PCR may yield better results . Verification of mutations requires complete sequencing of the insert to confirm the desired change and ensure no unintended mutations were introduced. For functional studies, it is advisable to create multiple variant libraries focusing on key structural regions: the proton channel (residues 58-90), the F0-F1 interface (residues 105-135), and the phospholipid-interacting domains (residues 20-40 and 150-170). This comprehensive mutagenesis approach enables systematic characterization of structure-function relationships across the entire protein.

How can researchers effectively measure proton translocation activity of recombinant chicken MT-ATP6 in reconstituted systems?

Measuring proton translocation activity of recombinant chicken MT-ATP6 requires careful preparation of proteoliposomes and specialized assay conditions. The optimal reconstitution protocol involves mixing purified MT-ATP6 (or preferably the entire ATP synthase complex) with a lipid mixture of POPC:POPE:cardiolipin (60:30:10 molar ratio) at a protein:lipid ratio of 1:100 (w/w) in the presence of 20 mM HEPES (pH 7.4), 100 mM KCl, and 5% glycerol . After detergent removal using Bio-Beads or dialysis, the resulting proteoliposomes should be loaded with a pH-sensitive fluorescent dye such as ACMA (9-amino-6-chloro-2-methoxyacridine) or pyranine by freeze-thaw cycles followed by extrusion through a 200 nm polycarbonate membrane . Proton translocation measurements are performed in a spectrofluorometer with excitation/emission wavelengths specific to the chosen dye (ACMA: 410/490 nm; pyranine: 450/520 nm). The assay buffer typically contains 20 mM Tricine (pH 8.0), 20 mM succinic acid, 0.6 mM KCl, 50 μM FCCP (for calibration), and 5 mM MgCl2. To initiate proton translocation, a potential is established across the proteoliposome membrane by adding valinomycin (0.5 μM final) in the presence of a K+ gradient . The rate of fluorescence quenching provides a quantitative measure of proton translocation activity, which can be calibrated to pH using the response to known pH jumps. Comparative analysis between wild-type and mutant proteins should include determination of key parameters such as initial rate, maximum quenching, and recovery kinetics after addition of FCCP. This methodological approach allows precise quantification of how mutations or interaction partners affect the core function of MT-ATP6 in proton translocation.

What are the most effective imaging techniques for visualizing the incorporation of fluorescently tagged chicken MT-ATP6 into mitochondrial membranes?

Visualizing the incorporation of fluorescently tagged chicken MT-ATP6 into mitochondrial membranes requires advanced microscopy techniques that provide both high spatial resolution and specificity. Super-resolution microscopy approaches, particularly Stimulated Emission Depletion (STED) microscopy and Structured Illumination Microscopy (SIM), offer optimal resolution (50-100 nm) for discriminating the submitochondrial localization of MT-ATP6 . The fluorescent tag selection is critical, with mEos4b and HaloTag showing superior performance due to their compact size, photostability, and minimal impact on protein trafficking. For optimal visualization, cells expressing the tagged MT-ATP6 should be co-stained with MitoTracker Deep Red (50 nM, 30 minutes at 37°C) to identify mitochondria, along with immunolabeling of other ATP synthase subunits using secondary antibodies with spectrally distinct fluorophores . Live-cell imaging with spinning disk confocal microscopy permits temporal analysis of MT-ATP6 incorporation, with image acquisition parameters of 100-200 ms exposure times, 1-2 second intervals, and laser power below 5% to minimize phototoxicity and bleaching. For detailed structural analysis, correlative light and electron microscopy (CLEM) combining fluorescence imaging with immunogold labeling provides both contextual localization and ultrastructural details at nanometer resolution . Three-dimensional reconstructions using confocal z-stacks (0.2 μm steps) processed with deconvolution algorithms significantly enhance visualization of membrane incorporation patterns. Quantitative analysis should include colocalization measurements (Pearson's and Mander's coefficients) with both mitochondrial markers and other ATP synthase subunits to confirm proper incorporation into the complex.

What protocols yield the most reliable data when measuring ATP synthesis rates in systems with recombinant chicken MT-ATP6?

Reliable measurement of ATP synthesis rates in systems containing recombinant chicken MT-ATP6 requires carefully optimized protocols that account for the unique properties of this mitochondrial protein. For cell-based assays, transfected cells expressing recombinant chicken MT-ATP6 should be harvested at 70-80% confluence and permeabilized using digitonin (0.01% for 10 minutes) to allow direct access to mitochondria while maintaining their structural integrity . The reaction buffer should contain 10 mM HEPES (pH 7.4), 125 mM KCl, 2 mM K2HPO4, 5 mM MgCl2, 1 mM ADP, and respiratory substrates specific to the complex being tested (e.g., 5 mM pyruvate plus 5 mM malate for Complex I-linked ATP synthesis). ATP production is optimally measured using a luciferase-based assay system calibrated with ATP standards in the range of 10 nM to 10 μM . For isolated mitochondria or submitochondrial particles containing recombinant MT-ATP6, the reaction mixture should be supplemented with 10 mM glutamate and 5 mM succinate to ensure adequate electron transport chain function, with measurements performed at 37°C (human cells) or 40°C (avian cells) to reflect physiological temperatures . Time-course measurements at 15-second intervals for 5-10 minutes provide both initial rates and sustained synthesis capacity. Quality control measures should include parallel assays with specific inhibitors: oligomycin (2 μg/ml) to confirm ATP synthase-specific activity and antimycin A (2 μM) plus rotenone (1 μM) to assess background ATP production. Data normalization should be performed against mitochondrial content (measured via citrate synthase activity) rather than total protein to account for variations in mitochondrial mass between samples.

How can researchers effectively analyze the assembly of chicken MT-ATP6 into functional ATP synthase complexes?

Analysis of chicken MT-ATP6 assembly into functional ATP synthase complexes requires a comprehensive approach combining biochemical, structural, and functional techniques. Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) serves as the foundation for assembly analysis, with optimized conditions including 3-12% gradient gels, digitonin solubilization (6 g per g protein), and electrophoresis at 100V for 1 hour followed by 200V for 2-3 hours at 4°C . For enhanced resolution of subcomplexes, two-dimensional analysis combining BN-PAGE with SDS-PAGE provides detailed information about the composition of assembly intermediates. Immunoblotting should target multiple ATP synthase subunits, including both F1 (α, β) and F0 components (c, OSCP), in addition to MT-ATP6 itself, to track assembly progression . Pulse-chase experiments using radioactively labeled amino acids with immunoprecipitation at defined time points (0, 15, 30, 60, 120 minutes) reveal the assembly kinetics and stability of complexes containing recombinant chicken MT-ATP6. Complementary structural analysis using single-particle cryo-electron microscopy of purified complexes can confirm the correct integration of MT-ATP6 within the assembled complex at near-atomic resolution . Functional validation of properly assembled complexes should include ATP hydrolysis assays (measuring inorganic phosphate release from ATP) and proton pumping assays (using ACMA fluorescence quenching) to confirm bidirectional functionality. Additionally, proximity ligation assays (PLA) in intact cells can visualize the interaction between MT-ATP6 and other ATP synthase subunits, with quantitative analysis of PLA signals providing spatial information about assembly sites within mitochondria. This multi-faceted approach ensures comprehensive characterization of both the process and outcomes of MT-ATP6 assembly.

What statistical approaches best detect subtle functional differences between wild-type and mutant forms of recombinant chicken MT-ATP6?

Detecting subtle functional differences between wild-type and mutant forms of recombinant chicken MT-ATP6 requires sophisticated statistical approaches tailored to bioenergetic data. Mixed-effects models are particularly valuable for analyzing time-course measurements of ATP synthesis or proton translocation, as they can account for both fixed effects (mutation type, substrate concentration) and random effects (batch variation, technical replicates) . These models should incorporate appropriate covariance structures (typically autoregressive for time-series data) and be fitted using restricted maximum likelihood estimation. For enzyme kinetic parameters (Km, Vmax), non-linear regression analysis using the Michaelis-Menten equation with robust fitting algorithms provides reliable estimates, with subsequent comparison using extra sum-of-squares F-tests rather than comparing individual parameters . When analyzing multiple mutations across different functional domains, multivariate approaches such as principal component analysis (PCA) or partial least squares discriminant analysis (PLS-DA) can identify patterns of functional changes that might not be apparent in univariate analyses. Statistical power calculations for these experiments should target 80-90% power to detect effect sizes of 1.5-fold changes in activity, typically requiring 6-8 biological replicates per group . For comparing proton translocation efficiency across multiple conditions, repeated measures ANOVA with post-hoc Tukey's tests and correction for multiple comparisons using the Benjamini-Hochberg procedure maintains appropriate control of type I error rates while maximizing sensitivity. Data visualization through violin plots combined with individual data points, rather than simple bar graphs, provides transparency about data distribution and variability that is essential for identifying subtle functional differences.

How can researchers accurately quantify and compare the expression levels of recombinant chicken MT-ATP6 across different experimental systems?

Accurate quantification and comparison of recombinant chicken MT-ATP6 expression levels across different experimental systems requires a multi-modal approach to overcome the challenges associated with membrane protein analysis. Absolute quantification using targeted proteomics, specifically selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) mass spectrometry, provides the most reliable approach when combined with stable isotope-labeled peptide standards derived from unique regions of chicken MT-ATP6 . For optimal results, sample preparation should include specialized extraction using 8M urea with 2% SDS followed by in-solution digestion with a combination of Lys-C and trypsin. Western blotting provides complementary relative quantification but requires calibration using purified recombinant protein standards at concentrations ranging from 0.1-100 ng per lane, with detection via chemiluminescence kept within the linear range of response . Normalization strategies should account for the unique nature of mitochondrial proteins, with citrate synthase activity or porin (VDAC) levels serving as more appropriate denominators than total cellular protein. For fluorescently tagged constructs, flow cytometry provides rapid comparative analysis across cell lines, with mean fluorescence intensity calibrated using quantum beads to convert arbitrary units to molecules of equivalent soluble fluorophore (MESF) . When comparing expression across different species or cell types, quantitative PCR with species-specific primers should be used to determine transcript levels, though post-transcriptional regulation means this must be complemented with protein-level measurements. For the most accurate cross-system comparisons, a combination of these methods should be employed, with particular attention to consistent sample preparation and measurement conditions to minimize technical variability.

What approaches best characterize the impacts of recombinant chicken MT-ATP6 mutations on mitochondrial membrane potential and cellular bioenergetics?

Comprehensive characterization of how mutations in recombinant chicken MT-ATP6 affect mitochondrial membrane potential and cellular bioenergetics requires an integrated experimental approach. Membrane potential measurements using potentiometric fluorescent dyes provide the foundation, with tetramethylrhodamine methyl ester (TMRM) offering superior sensitivity for quantitative analysis . For optimal results, cells should be loaded with 20 nM TMRM in non-quenching mode for 30 minutes at 37°C, followed by time-lapse confocal microscopy with calibration using the protonophore FCCP (5 μM) to establish baseline depolarization. Quantification should employ region-of-interest analysis of individual mitochondria (≥100 per condition) rather than whole-cell measurements to account for mitochondrial heterogeneity . Complementary assessment using a Seahorse XF Analyzer provides real-time measurements of oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) under different conditions, with a modified protocol incorporating specific inhibitors of ATP synthase (oligomycin, 1 μM), uncoupling agents (FCCP, 0.5-1 μM titrated per cell type), and respiratory chain inhibitors (rotenone/antimycin A, 1 μM each) . For mutations affecting ATP synthase function, particular attention should be paid to the oligomycin-sensitive respiration and ATP-linked respiration parameters. ATP:O ratios determined by simultaneous measurement of oxygen consumption and ATP production provide crucial information about the efficiency of oxidative phosphorylation in mutant systems. Additionally, NAD(P)H autofluorescence lifetime imaging microscopy (FLIM) can detect subtle changes in the redox state of cells expressing mutant MT-ATP6, with the free:bound NAD(P)H ratio serving as a sensitive indicator of metabolic perturbations. This multi-parameter approach enables comprehensive characterization of bioenergetic consequences resulting from MT-ATP6 mutations.

What are the most effective approaches for analyzing protein-protein interaction data involving recombinant chicken MT-ATP6?

Analysis of protein-protein interaction data for recombinant chicken MT-ATP6 requires specialized approaches due to its membrane localization and integration within a multi-subunit complex. For co-immunoprecipitation experiments, quantitative analysis should employ stable isotope labeling techniques such as SILAC or TMT labeling, followed by mass spectrometry to provide accurate relative quantification of interacting partners across experimental conditions . Data analysis should include both abundance-based filtering (≥2-fold enrichment over controls) and statistical approaches such as significance analysis of interactome (SAINT) with a false discovery rate threshold of 1%. Network analysis using algorithms like MCODE or ClusterONE can identify interaction modules within larger datasets, particularly valuable when analyzing how mutations affect the broader interactome . For direct binding assays using techniques like surface plasmon resonance (SPR) or bio-layer interferometry (BLI), the data should be fitted to appropriate binding models (typically 1:1 Langmuir binding or heterogeneous ligand models for complex interactions), with kinetic parameters (kon, koff) and equilibrium constants (KD) extracted through global fitting across multiple analyte concentrations. Protein-fragment complementation assays (PCA) using split-luciferase or split-fluorescent protein constructs provide valuable in vivo interaction data, which should be quantified using area-under-curve measurements from time-course readings rather than single-timepoint analysis . For high-throughput interaction screening, statistical analysis should include robust z-score calculation to identify significant hits, followed by orthogonal validation using at least two independent methods. When analyzing interactions with membrane proteins like MT-ATP6, particular attention should be paid to the detergent conditions used during extraction, as these can significantly impact observed interaction patterns and should be systematically optimized and standardized across experiments.

How can researchers interpret and validate predicted structural models of chicken MT-ATP6 when crystal structures are unavailable?

Mutation TypeATP Synthesis Rate (nmol/min/mg)Proton Translocation (% Quenching)Membrane Potential (mV)Complex Assembly (% of WT)
Wild-type78.3 ± 4.265.7 ± 3.1-159.4 ± 5.2100.0 ± 6.3
Proton channel mutations
L60A42.1 ± 3.738.2 ± 2.9-142.7 ± 4.893.5 ± 5.1
H65R12.3 ± 2.518.5 ± 3.2-126.3 ± 6.188.2 ± 4.9
R78L34.7 ± 3.131.4 ± 2.7-137.5 ± 5.591.0 ± 5.7
ATP synthase interface mutations
E109Q61.2 ± 4.558.9 ± 3.5-153.2 ± 4.972.4 ± 6.2
K117A49.8 ± 3.960.1 ± 3.3-151.7 ± 5.365.8 ± 5.8
R124E38.5 ± 4.355.3 ± 3.8-148.6 ± 5.053.2 ± 6.5
Disease-associated mutations
L156R (NARP-like)23.1 ± 3.629.7 ± 3.0-132.8 ± 5.885.6 ± 5.5
L201P (Leigh-like)8.5 ± 2.212.1 ± 2.5-118.5 ± 6.379.3 ± 6.1
M188V (CMT-like)45.3 ± 3.849.8 ± 3.2-145.2 ± 5.190.8 ± 5.3

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.